Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arcticzymes Tech | Oslo | Healthcare | Biotechnology & Medical Research | NOK 947.88M | 123.7x | -2.2 | NOK 18.56 | -5.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.6% Downside | Upgrade to Pro+ | |
Nykode Therapeutics | Oslo | Healthcare | Biotechnology & Medical Research | NOK 688.36M | -1.9x | NOK 2.02 | -4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Thor Medical | Oslo | Healthcare | Biotechnology & Medical Research | NOK 606.81M | -34.5x | NOK 1.93 | -3.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Lytix Biopharma AS | Oslo | Healthcare | Biotechnology & Medical Research | NOK 353.60M | -3.2x | -0.18 | NOK 5.10 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Exact Therapeutics AS | Oslo | Healthcare | Biotechnology & Medical Research | NOK 242.93M | -3.5x | 0.12 | NOK 3.20 | -16.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lifecare | Oslo | Healthcare | Biotechnology & Medical Research | NOK 173.58M | -2.1x | 0.05 | NOK 11.40 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zelluna | Oslo | Healthcare | Biotechnology & Medical Research | NOK 74.15M | -0.4x | 0.06 | NOK 2.11 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SoftOx Solutions | Oslo | Healthcare | Biotechnology & Medical Research | NOK 64.78M | NOK 0.03 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Bergenbio | Oslo | Healthcare | Biotechnology & Medical Research | NOK 59.41M | -0.4x | -0.01 | NOK 1.52 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | |
PCI Biotech | Oslo | Healthcare | Biotechnology & Medical Research | NOK 50.02M | -3x | -0.15 | NOK 1.31 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Circio Holding | Oslo | Healthcare | Biotechnology & Medical Research | NOK 48.17M | 0.5x | 0.05 | NOK 0.60 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |